Submission Number: 28343
Submission ID: 126096
Submission UUID: 24b4fa20-ac08-4ac6-8d57-1978f426d0eb

Created: Thu, 06/26/2025 - 16:45
Completed: Thu, 06/26/2025 - 16:45
Changed: Fri, 06/27/2025 - 15:39

Remote IP address: (unknown)
Submitted by: jill.simonetti_1
Language: English

Is draft: No

Locked: Yes
Health Department
Regents of the University of Minnesota
193170
Congenital Cytomegalovirus screening using newborn dried blood spots
{Empty}
The State has a contract with the Contractor identified as Contract 107507 to provide lab services to address the clinical sensitivity of polymerase chain reaction (PCR) performed on the newborn dried blood spot (DBS) in the context of universal newborn screening. In addition, for positive results, amplification of DNA for cytomegalovirus (CMV) genotyping, using the glycoprotein B genotyping approach is needed. This work will help the newborn screening program determine if using DBS for screening is feasible.
Project Duration
Fri, 04/01/2016 - 00:00
Fri, 03/31/2017 - 00:00
Wed, 03/31/2021 - 00:00
Yes
{Empty}
Contract Amounts
$125959.00
$1484026.00
$1609985.00
Yes
CDC
Yes
This procedure was developed by Dr. Mark Schleiss and is only able to be performed in his laboratory at the University of Minnesota. This work is part of a CDC awarded grant.

Jill Simonetti
jill.simonetti@state.mn.us
Acceptable
Excellent
Acceptable
Excellent
Yes
n/a
4 - satisfied